Skip to content
2000
Volume 23, Issue 29
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Mexiletine is an oral class IB antiarrhythmic agent. Although it was primarily studied for the treatment of ventricular arrhythmias, it has been demonstrated to be useful also for the treatment of chronic painful diabetic neuropathy, neuropathic pain, skeletal muscle channelopathies, and recently amyotrophic lateral sclerosis. This review presents a detailed report on the different synthetic routes to racemic and homochiral mexiletine developed in the last decades, as well as analytical studies regarding enantioseparation methods and enantiomeric excess determination. Finally, some analogues of mexiletine reported in the literature, most of which along with pharmacological studies, have been mentioned.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867323666160517120234
2016-08-01
2025-09-02
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867323666160517120234
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test